Nisa Investment Advisors’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1K | Buy |
705
+23
| +3% | +$461 | ﹤0.01% | 2100 |
|
|
2025
Q1 | $13.4K | Sell |
682
-11
| -2% | -$216 | ﹤0.01% | 2020 |
|
|
2024
Q4 | $15.6K | Buy |
693
+31
| +5% | +$698 | ﹤0.01% | 2016 |
|
|
2024
Q3 | $16.9K | Buy |
662
+607
| +1,104% | +$15.5K | ﹤0.01% | 1962 |
|
|
2024
Q2 | $1.29K | Buy |
55
+40
| +267% | +$935 | ﹤0.01% | 2463 |
|
|
2024
Q1 | $264 | Buy |
15
+6
| +67% | +$106 | ﹤0.01% | 2604 |
|
|
2023
Q4 | $125 | Hold |
9
| – | – | ﹤0.01% | 2602 |
|
|
2023
Q3 | $123 | Sell |
9
-7
| -44% | -$96 | ﹤0.01% | 2715 |
|
|
2023
Q2 | $327 | Buy |
+16
| New | +$327 | ﹤0.01% | 2644 |
|